FDA approves Sandoz generic
ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of a drug by Pharmacia and Upjohn, agency records show.
The FDA approved Sandoz methylprednisolone acetate injection in the 40 mg-per-milliliter and 80 mg-per-milliliter strengths, a generic version of Depo-Medrol. The drug is used to treat inflammatory diseases.
Pharmacia and Upjohn is now a part of Pfizer. Depo-Medrol originally received approval in 1959.
Watson, Elan Corp. settle patent infringement suit
CORONA, Calif. Generic drug maker Watson Pharmaceuticals has settled with Irish pharmaceutical and biotech company Elan Corp. concerning patent litigation surrounding Watson’s generic version of an Elan drug.
Under the terms of the agreement, Watson will pay Elan $18 million to settle disputes over the development, manufacturing, marketing and sale of its generic version of the pain drug Naprelan (naproxen sodium). Watson also agreed not to market or sell its version until the expiration of Elan’s patent for the drug, which will occur in 2014, according to the Food and Drug Administration’s Orange Book.
In August, the United States District Court for the Southern District of Florida ruled that Watson’s generic Naprelan infringed Elan’s ‘320 patent on the drug.
Centice launches a Web site dedicated to Pass Rx
MORRISVILLE, N.C. Centice Corporation has launched a Web site about its Pass Rx dispensing machine.
The company said it developed the site for pharmacists to learn about the Pass Rx system, including how to implement and use it.
“The launch of our new Web site will help get the word out about the availability and benefits of Pass Rx,” Centice president and CEO Ray Swanson said in a statement. “We are very excited to provide our customers with a new venue to learn more about Pass Rx and how the system can benefit their pharmacy by increasing their patients’ safety, improving the quality control process and overall workflow efficiency.”